• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与高血压、心力衰竭及冠心病——风险因素、矛盾之处及减肥建议

Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss.

作者信息

Artham Surya M, Lavie Carl J, Milani Richard V, Ventura Hector O

机构信息

Ochsner Clinic Foundation, New Orleans, LA.

出版信息

Ochsner J. 2009 Fall;9(3):124-32.

PMID:21603427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3096264/
Abstract

Obesity prevalence has reached epidemic proportions and is independently associated with numerous cardiovascular disease (CVD) risk factors, including diabetes mellitus, hypertension, dyslipidemia, cancers, sleep apnea, and other major CVDs. Obesity has significant negative impact on CVD, including hypertension, coronary heart disease, heart failure, and arrhythmias via its maladaptive effects on individual CVD risk factors and cardiac structure and function. Despite this negative association between obesity and the incidence and prevalence of CVD, many studies have demonstrated that obese patients with established CVD might have better short- and long-term prognosis, suggesting an "obesity paradox." This intriguing phenomenon has been well documented in populations with heart failure, coronary heart disease, and hypertension. This review summarizes the adverse effects of obesity on individual CVD risk factors; its role in the genesis of CVDs, including heart failure, coronary heart disease, and hypertension; and the obesity paradox observed in these populations and the potential underlying mechanisms behind this puzzling phenomenon and concludes with a discussion on the potential benefits of weight reduction.

摘要

肥胖患病率已达到流行程度,并与众多心血管疾病(CVD)风险因素独立相关,包括糖尿病、高血压、血脂异常、癌症、睡眠呼吸暂停及其他主要心血管疾病。肥胖通过对个体心血管疾病风险因素以及心脏结构和功能产生适应不良影响,对心血管疾病有显著负面影响,包括高血压、冠心病、心力衰竭和心律失常。尽管肥胖与心血管疾病的发病率和患病率之间存在这种负相关关系,但许多研究表明,患有已确诊心血管疾病的肥胖患者可能有较好的短期和长期预后,这表明存在“肥胖悖论”。这种有趣的现象在心力衰竭、冠心病和高血压人群中已有充分记录。本综述总结了肥胖对个体心血管疾病风险因素的不良影响;其在心血管疾病发生中的作用,包括心力衰竭、冠心病和高血压;以及在这些人群中观察到的肥胖悖论及其背后潜在的机制,并最后讨论了体重减轻的潜在益处。

相似文献

1
Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss.肥胖与高血压、心力衰竭及冠心病——风险因素、矛盾之处及减肥建议
Ochsner J. 2009 Fall;9(3):124-32.
2
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.肥胖与心血管疾病:风险因素、矛盾之处及体重减轻的影响。
J Am Coll Cardiol. 2009 May 26;53(21):1925-32. doi: 10.1016/j.jacc.2008.12.068.
3
The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases.肥胖悖论:肥胖对心血管疾病患病率和预后的影响
Postgrad Med. 2008 Jul;120(2):34-41. doi: 10.3810/pgm.2008.07.1788.
4
Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.肥胖和肥胖悖论对心力衰竭患病率和预后的影响。
JACC Heart Fail. 2013 Apr;1(2):93-102. doi: 10.1016/j.jchf.2013.01.006. Epub 2013 Apr 1.
5
The Interaction of Cardiorespiratory Fitness With Obesity and the Obesity Paradox in Cardiovascular Disease.心肺适能与肥胖的相互作用及心血管疾病中的肥胖悖论
Prog Cardiovasc Dis. 2017 Jun-Jul;60(1):30-44. doi: 10.1016/j.pcad.2017.05.005. Epub 2017 May 12.
6
Management of cardiovascular diseases in patients with obesity.肥胖患者的心血管疾病管理。
Nat Rev Cardiol. 2018 Jan;15(1):45-56. doi: 10.1038/nrcardio.2017.108. Epub 2017 Jul 27.
7
Updates on obesity and the obesity paradox in cardiovascular diseases.肥胖与心血管疾病中肥胖悖论的研究进展。
Prog Cardiovasc Dis. 2023 May-Jun;78:2-10. doi: 10.1016/j.pcad.2022.11.013. Epub 2022 Dec 5.
8
Obesity and CardiovascularDiseases.肥胖与心血管疾病
Curr Probl Cardiol. 2017 Nov;42(11):376-394. doi: 10.1016/j.cpcardiol.2017.04.004. Epub 2017 Apr 13.
9
Effects of Bariatric Surgery on Cardiovascular Disease: A Concise Update of Recent Advances.减肥手术对心血管疾病的影响:近期进展简要更新
Front Cardiovasc Med. 2019 Jul 10;6:94. doi: 10.3389/fcvm.2019.00094. eCollection 2019.
10
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.肥胖与心血管疾病:病理生理学、评估及体重减轻的影响:营养、身体活动与新陈代谢委员会肥胖问题委员会对1997年美国心脏协会关于肥胖与心脏病科学声明的更新
Circulation. 2006 Feb 14;113(6):898-918. doi: 10.1161/CIRCULATIONAHA.106.171016. Epub 2005 Dec 27.

引用本文的文献

1
Emerging Role of Weight-Loss Medications in the Management of Heart Failure: Current Evidence and Future Perspectives.减肥药物在心力衰竭管理中的新作用:当前证据与未来展望
Am J Cardiovasc Drugs. 2025 May 28. doi: 10.1007/s40256-025-00735-y.
2
Weight loss dynamics after laparoscopic sleeve gastrectomy: a retrospective single center analysis with age and preoperative weight stratification.腹腔镜袖状胃切除术后的体重减轻动态变化:一项基于年龄和术前体重分层的单中心回顾性分析
Sci Rep. 2025 Mar 13;15(1):8771. doi: 10.1038/s41598-025-93826-4.
3
Bariatric Surgery in Obesity: Metabolic Quality Analysis and Comparison of Surgical Options.肥胖症的减重手术:代谢质量分析及手术方案比较。
Adv Exp Med Biol. 2024;1460:697-726. doi: 10.1007/978-3-031-63657-8_24.
4
Association of Body Mass Index with Outcomes in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).体重指数与射血分数降低的心力衰竭(HFrEF)患者结局的关系。
Nutrients. 2024 Jul 30;16(15):2473. doi: 10.3390/nu16152473.
5
A Randomized Controlled Trial Investigating the Impact of a Low-Calorie Dietary Approach to Stop Hypertension (DASH) on Anthropometric and Glycemic Measures in Patients Experiencing Weight Regain 2 Years Post Sleeve Surgery.一项随机对照试验研究了低热量饮食控制高血压(DASH)方案对袖状胃切除术后 2 年体重反弹患者的人体测量学和血糖指标的影响。
Obes Surg. 2024 Mar;34(3):892-901. doi: 10.1007/s11695-024-07057-z. Epub 2024 Jan 13.
6
Comprehensive Review of Anesthetic Evaluation and Management in Obese Female Patients Undergoing In Vitro Fertilization.肥胖女性患者体外受精麻醉评估与管理的综合综述
Cureus. 2023 Oct 23;15(10):e47521. doi: 10.7759/cureus.47521. eCollection 2023 Oct.
7
BMI is not independently associated with coronary artery calcification in a large single-center CT cohort.在一个大型单中心CT队列中,体重指数与冠状动脉钙化并无独立关联。
Obes Sci Pract. 2022 Sep 7;9(2):172-178. doi: 10.1002/osp4.636. eCollection 2023 Apr.
8
The Na/K-ATPase: A potential therapeutic target in cardiometabolic diseases.钠钾 ATP 酶:心脏代谢疾病的潜在治疗靶点。
Front Endocrinol (Lausanne). 2023 Feb 28;14:1150171. doi: 10.3389/fendo.2023.1150171. eCollection 2023.
9
Non-invasive photoacoustic computed tomography of rat heart anatomy and function.大鼠心脏解剖结构与功能的无创光声计算机断层扫描
Light Sci Appl. 2023 Jan 3;12(1):12. doi: 10.1038/s41377-022-01053-7.
10
Long Term Metabolic Effects of Sacubitril/Valsartan in Non-Diabetic and Diabetic Patients With Heart Failure Reduced Ejection Fraction: A Real Life Study.沙库巴曲缬沙坦对射血分数降低的非糖尿病和糖尿病心力衰竭患者的长期代谢影响:一项真实世界研究
Front Physiol. 2022 May 25;13:897109. doi: 10.3389/fphys.2022.897109. eCollection 2022.

本文引用的文献

1
Impact of left ventricular geometry on prognosis-a review of ochsner studies.左心室几何形态对预后的影响——奥施纳研究综述
Ochsner J. 2008 Spring;8(1):11-7.
2
Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function.8088例收缩功能保留的老年患者中肥胖与左心室几何形态对死亡率的不同影响。
Postgrad Med. 2009 May;121(3):119-25. doi: 10.3810/pgm.2009.05.2011.
3
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.肥胖与心血管疾病:风险因素、矛盾之处及体重减轻的影响。
J Am Coll Cardiol. 2009 May 26;53(21):1925-32. doi: 10.1016/j.jacc.2008.12.068.
4
Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure.肥胖症手术治疗重度收缩期心力衰竭的病态肥胖患者的安全性和有效性。
Clin Cardiol. 2008 Nov;31(11):516-20. doi: 10.1002/clc.20315.
5
The "obesity paradox": is smoking/lung disease the explanation?“肥胖悖论”:吸烟/肺部疾病是其解释吗?
Chest. 2008 Nov;134(5):896-898. doi: 10.1378/chest.08-1673.
6
Impact of obesity on the pathogenesis and prognosis of coronary heart disease.肥胖对冠心病发病机制及预后的影响。
J Cardiometab Syndr. 2008 Summer;3(3):162-7. doi: 10.1111/j.1559-4572.2008.00004.x.
7
Impact of obesity on the risk of heart failure and its prognosis.肥胖对心力衰竭风险及其预后的影响。
J Cardiometab Syndr. 2008 Summer;3(3):155-61. doi: 10.1111/j.1559-4572.2008.00001.x.
8
Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients.心脏康复对肥胖冠心病患者冠状动脉危险因素、炎症及代谢综合征的影响。
J Cardiometab Syndr. 2008 Summer;3(3):136-40. doi: 10.1111/j.1559-4572.2008.00002.x.
9
Which measures of obesity best predict cardiovascular risk?哪种肥胖指标最能预测心血管风险?
J Am Coll Cardiol. 2008 Aug 19;52(8):616-9. doi: 10.1016/j.jacc.2008.05.017.
10
Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study.减肥手术对代谢综合征的影响:一项基于人群的长期对照研究。
Mayo Clin Proc. 2008 Aug;83(8):897-907. doi: 10.4065/83.8.897.